OTCPK:CBDS

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. More Details


Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

Share Price & News

How has Cannabis Sativa's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: CBDS's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

-12.8%

CBDS

-2.3%

US Healthcare

-0.8%

US Market


1 Year Return

-62.7%

CBDS

21.0%

US Healthcare

13.8%

US Market

Return vs Industry: CBDS underperformed the US Healthcare industry which returned 21% over the past year.

Return vs Market: CBDS underperformed the US Market which returned 13.8% over the past year.


Shareholder returns

CBDSIndustryMarket
7 Day-12.8%-2.3%-0.8%
30 Day-31.7%-4.3%-5.0%
90 Day-44.9%1.8%10.1%
1 Year-62.7%-62.7%22.6%21.0%16.4%13.8%
3 Year-87.6%-87.6%23.9%18.5%36.9%27.8%
5 Year-82.0%-82.0%50.1%39.4%85.0%64.2%

Price Volatility Vs. Market

How volatile is Cannabis Sativa's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Cannabis Sativa undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: CBDS ($0.37) is trading below our estimate of fair value ($1.11)

Significantly Below Fair Value: CBDS is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: CBDS is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: CBDS is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate CBDS's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: CBDS is overvalued based on its PB Ratio (12.8x) compared to the US Healthcare industry average (2.8x).


Next Steps

Future Growth

How is Cannabis Sativa forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Cannabis Sativa has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Take a look at our analysis of CBDS’s management and see if the CEO’s compensation is within a reasonable range, who is on the board and if insiders have been trading lately.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Cannabis Sativa's filings and announcementshere.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Cannabis Sativa performed over the past 5 years?

29.6%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: CBDS is currently unprofitable.

Growing Profit Margin: CBDS is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: CBDS is unprofitable, but has reduced losses over the past 5 years at a rate of 29.6% per year.

Accelerating Growth: Unable to compare CBDS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: CBDS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).


Return on Equity

High ROE: CBDS has a negative Return on Equity (-194.78%), as it is currently unprofitable.


Next Steps

Financial Health

How is Cannabis Sativa's financial position?


Financial Position Analysis

Short Term Liabilities: CBDS's short term assets ($541.9K) do not cover its short term liabilities ($1.4M).

Long Term Liabilities: CBDS's short term assets ($541.9K) exceed its long term liabilities ($32.2K).


Debt to Equity History and Analysis

Debt Level: CBDS's debt to equity ratio (57.2%) is considered high.

Reducing Debt: CBDS's debt to equity ratio has increased from 14.2% to 57.2% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable CBDS has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: CBDS is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 5.8% per year.


Next Steps

Dividend

What is Cannabis Sativa current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate CBDS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate CBDS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if CBDS's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if CBDS's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of CBDS's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.7yrs

Average management tenure


CEO

David Tobias (69 yo)

1.67yrs

Tenure

US$428,572

Compensation

Mr. David M. Tobias has been an Independent Director of MJ Harvest, Inc. since November 03, 2017. Mr. Tobias has been President of Wild Earth Naturals since May, 2013. Mr. Tobias served as the President of ...


Leadership Team

NamePositionTenureCompensationOwnership
David Tobias
CEO, President1.67yrsUS$428.57k13.11%
$ 1.3m
Catherine Carroll
Treasurer & Director7.17yrsUS$111.11k1.73%
$ 169.1k
Brad Herr
CFO & Director0.67yrno data0.81%
$ 78.7k
Carolyn Merrill
Controllerno dataUS$63.66kno data

1.7yrs

Average Tenure

67.5yo

Average Age

Experienced Management: CBDS's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
David Tobias
CEO, President1.67yrsUS$428.57k13.11%
$ 1.3m
Catherine Carroll
Treasurer & Director7.17yrsUS$111.11k1.73%
$ 169.1k
Brad Herr
CFO & Director0.67yrno data0.81%
$ 78.7k
Trevor Reed
Independent Director3.67yrsno data0.40%
$ 38.8k
Robert Tankson
Director0.67yrno data0.71%
$ 69.3k

3.7yrs

Average Tenure

66yo

Average Age

Experienced Board: CBDS's board of directors are considered experienced (3.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: CBDS insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 19.4%.


Top Shareholders

Company Information

Cannabis Sativa, Inc.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Cannabis Sativa, Inc.
  • Ticker: CBDS
  • Exchange: OTCPK
  • Founded: 2004
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: US$9.755m
  • Shares outstanding: 26.44m
  • Website: https://cannabissativainc.com

Number of Employees


Location

  • Cannabis Sativa, Inc.
  • PO Box 1602
  • Mesquite
  • Nevada
  • 89024
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
CBDSOTCPK (Pink Sheets LLC)YesCommon StockUSUSDJul 2013
9C4MUN (Boerse Muenchen)YesCommon StockDEEURJul 2013

Biography

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. It operates through three divi ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/27 06:08
End of Day Share Price2020/09/25 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.